There are more self-policing initiatives from within the industry compared to four years ago, when a senate informational hearing brought the weight management supplement category to national attention, argued Steve Mister, CEO and president of the trade...
The term ‘weight management supplement’ may conjure associations with the passé and unpopular ‘weight loss pill,’ despite the diversity of delivery formats and functions the category offers consumers.
A bill that seeks to restrict the ability to provide nutrition advice to only a small group of accredited professionals has advanced farther than it ever has in the New York State legislature.
The new name of the Botanical Adulterants Prevention Program better identifies it, but doesn’t change the underlying principles on which is it grounded.
By Michael McGuffin, president, American Herbal Products Association
The herbal industry continued to evolve in 2017 to meet the steadily increasing demand for high quality botanical ingredients in an array of consumer goods from teas and health supplements to personal care products and Traditional Chinese Medicine.
Three members of Congress have sent a letter to the US Food and Drug Administration requesting specifics on how enforcement funds are allocated. The three lawmakers are among those the Council for Responsible Nutrition has worked closely with on regulatory...
A bill now before the US House of Representatives that seeks to clarify the boundaries of Multi Level Marketing operations is imperfect but better than the status quo, said an attorney familiar with the sector.
A recent commentary published by three experts in the dietary supplement industry cautions against drawing big conclusions from aggregate data from poison control centers.
The funding arm of the Council for Responsible Nutrition has renewed its support for the NAD dietary supplement advertising review program for an additional three years.
Will compiling an official list of Old Dietary Ingredients ultimately be worth the effort? Maybe, but the resulting list must be expansive rather than restrictive to be of much use, most stakeholders agree.
A new study conducted by anti doping researchers has found that products containing SARMs are readily available online and that many of the products contain additional undeclared, unapproved drugs.
FDA commissioner Scott Gottlieb has warned about the ‘deadly risks’ associated with kratom and has said the agency “must use its authority to protect the public from addictive substances like kratom.”
The Food and Drug Administration has issued a consumer warning against supplement-like body building products that contain SARMs, or selective androgen receptor modulators.
A Massachusetts legislator’s attempt to restrict the sale of some dietary supplements seems doomed to fail in its latest iteration, but continued vigilance is needed, according to the head of the Natural Products Association.
